GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Gaush Meditech Ltd (HKSE:02407) » Definitions » Price-to-Operating-Cash-Flow

Gaush Meditech (HKSE:02407) Price-to-Operating-Cash-Flow : 13.31 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gaush Meditech Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Gaush Meditech's share price is HK$15.98. Gaush Meditech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.20. Hence, Gaush Meditech's Price-to-Operating-Cash-Flow Ratio for today is 13.31.

The historical rank and industry rank for Gaush Meditech's Price-to-Operating-Cash-Flow or its related term are showing as below:

HKSE:02407' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 9.24   Med: 15.69   Max: 24.54
Current: 13.29

During the past 5 years, Gaush Meditech's highest Price-to-Operating-Cash-Flow Ratio was 24.54. The lowest was 9.24. And the median was 15.69.

HKSE:02407's Price-to-Operating-Cash-Flow is ranked better than
69.48% of 439 companies
in the Medical Devices & Instruments industry
Industry Median: 20.61 vs HKSE:02407: 13.29

Gaush Meditech's Cash Flow from Operations per share for the six months ended in Dec. 2023 was HK$0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.20.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Gaush Meditech was -31.90% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 20.90% per year.

During the past 5 years, Gaush Meditech's highest 3-Year average Operating Cash Flow per Share Growth Rate was 28.00% per year. The lowest was 20.90% per year. And the median was 24.45% per year.


Gaush Meditech Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Gaush Meditech's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gaush Meditech Price-to-Operating-Cash-Flow Chart

Gaush Meditech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
- - - 19.09 20.54

Gaush Meditech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial - - 19.09 - 20.54

Competitive Comparison of Gaush Meditech's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, Gaush Meditech's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gaush Meditech's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Gaush Meditech's Price-to-Operating-Cash-Flow falls into.



Gaush Meditech Price-to-Operating-Cash-Flow Calculation

Gaush Meditech's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=15.98/1.201
=13.31

Gaush Meditech's Share Price of today is HK$15.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.20.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Gaush Meditech Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Gaush Meditech's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Gaush Meditech (HKSE:02407) Business Description

Traded in Other Exchanges
Address
No.11 Dongzhimen South Avenue, Room 1901, Building A, Zhonghui Plaza, Dongcheng District, Beijing, CHN
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Executives
Orbimed Advisors Iii Limited 2102 Investment manager
Orbimed Asia Gp Iii, L.p. 2102 Investment manager
Orbimed Asia Partners Iii, L.p. 2102 Investment manager
Gao Tieta 2201 Interest of corporation controlled by you
Gaush Holding Ltd 2101 Beneficial owner
Cuprite Gem Investments Ltd 2101 Beneficial owner
Warburg Pincus (bermuda) Private Equity Gp Ltd. 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp Llc 2201 Interest of corporation controlled by you
Warburg Pincus (cayman) China-southeast Asia Ii Gp, L.p. 2201 Interest of corporation controlled by you
Warburg Pincus China-southeast Asia Ii (cayman), L.p. 2201 Interest of corporation controlled by you
Warburg Pincus Partners Ii (cayman), L.p. 2201 Interest of corporation controlled by you

Gaush Meditech (HKSE:02407) Headlines

No Headlines